Press releases
- 4basebio Plc - 4basebio announces the supply of its opDNA™ DNA products into Tier 1 Pharma client's vaccine program
- 4basebio Plc - 4basebio client's Phase I clinical trials for opDNA™ based mRNA vaccine
- 4basebio Plc - 4basebio awarded tender to deliver research and GMP-grade synthetic DNA in CPI's tender process for supplying its RNA Centre of Excellence
- 4basebio Plc - Holding(s) in Company
- 4basebio Plc - Exercise of Options
- 4basebio Plc - Directors' Dealings
- 4basebio Plc - Long-Term Incentive Plan and Exercise of Options
More ▼
Key statistics
52-week range
Open | 11.50 |
---|---|
High | 12.40 |
Low | 10.70 |
Bid | 11.00 |
Offer | 12.80 |
Previous close | 11.50 |
Average volume | 2.00k |
---|---|
Shares outstanding | 12.81m |
Free float | 3.89m |
P/E (TTM) | -- |
Market cap | 132.53m GBP |
EPS (TTM) | -0.5094 GBP |
Data delayed at least 15 minutes, as of Apr 18 2024 20:43 BST.
More ▼